New therapy reprograms immune cells inside tumors to attack cancer, bypassing traditional cell therapy manufacturing ...

Engineered yeast cells can mimic real cancer cells and be used to test new cancer immunotherapies much faster, benefiting patients.

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Two decades after a breast cancer vaccine trial, every participant is still alive—an astonishing result for metastatic ...

A newly identified metabolite in human feces improves immunotherapy and could radically change the treatment of lung cancer.

Researchers have evidence that inside shark DNA are single chain antibodies that just might help cure cancer. These flexible, “sticky” antibodies can grab onto cancer cells remarkably well, and hold ...

A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening cancer vaccines. Scientists have now developed a drug that shuts down this ...

A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to study a delayed release preparation, or wafer, of an immunostimulatory ...

Cholera toxin shows promise against colon cancer by targeting tumors precisely while sparing healthy tissue, unlike brutal ...

Knowable Magazine reports on advancements in pancreatic cancer treatment, including new drugs, vaccines, and early diagnostic ...

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...